Martini Andrea, Ceranto Elena, Gatta Angelo, Angeli Paolo, Pontisso Patrizia
Internal Medicine and Hepatology, Regional Referral Center for Liver Disease, Department of Medicine, University of Padua, Italy.
United European Gastroenterol J. 2017 Nov;5(7):982-986. doi: 10.1177/2050640617696402. Epub 2017 Feb 26.
Cirrhosis represents the end stage of chronic liver disease, characterized by high mortality and morbidity. The prevalence of liver disease is difficult to assess, given its clinical latency up to the late stage.
We aimed to assess the prevalence of unrecognized chronic liver disease and cirrhosis using surrogate indicators from medical records of family physicians.
Medical records of 139,104 subjects, collected from 99 family physicians of the Veneto region, were used. Persistently high transaminases were used as indicators of occult chronic liver disease; thrombocytopenia, unrelated to haematological malignancies, was used as indicator of occult cirrhosis. Diagnosis of chronic liver disease and cirrhosis was assessed using ICD9-CM-1997 codes.
Alteration of transaminases was found in 32.7% of the subjects, and among them only one-third had an already diagnosed liver disease. Patients with diagnosis of cirrhosis were 0.3%, while thrombocytopenia, indicator of occult cirrhosis, was detected in 1.3% of the remaining population. Patients with overt and occult cirrhosis showed a higher metabolic profile, with significantly higher prevalence of arterial hypertension, obesity and diabetes than the general population.
A large proportion of patients with chronic liver disease is still undiagnosed. Surrogate biochemical indicators might be useful for disease recognition.
肝硬化是慢性肝病的终末期,具有高死亡率和高发病率。鉴于肝病在晚期之前存在临床潜伏期,其患病率难以评估。
我们旨在使用家庭医生病历中的替代指标评估未被识别的慢性肝病和肝硬化的患病率。
使用从威尼托地区99名家庭医生收集的139104名受试者的病历。持续高转氨酶用作隐匿性慢性肝病的指标;与血液系统恶性肿瘤无关的血小板减少用作隐匿性肝硬化的指标。使用ICD9-CM-1997编码评估慢性肝病和肝硬化的诊断。
32.7%的受试者发现转氨酶异常,其中只有三分之一已被诊断患有肝病。肝硬化诊断患者为0.3%,而在其余人群中1.3%检测到隐匿性肝硬化指标血小板减少。显性和隐匿性肝硬化患者表现出更高的代谢特征,动脉高血压、肥胖和糖尿病的患病率明显高于普通人群。
很大一部分慢性肝病患者仍未被诊断。替代生化指标可能有助于疾病识别。